Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Martin Gartland

Switch From Tenofovir Disoproxil Fumarate Combination to Dolutegravir Plus Rilpivirine Improves Parameters of Bone Health

AIDS
Infectious DiseasesAllergyImmunology
2017English

96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

Related publications

First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2018English

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2020English

An Improved Process for the Preparation of Tenofovir Disoproxil Fumarate

English

An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy

PLoS ONE
Multidisciplinary
2016English

Switching to Coformulated Rilpivirine (RPV), Emtricitabine (FTC) and Tenofovir Alafenamide From Either RPV, FTC and Tenofovir Disoproxil Fumarate (TDF) or Efavirenz, FTC and TDF: 96-Week Results From Two Randomized Clinical Trials

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2018English

In VitroVirology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir With Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

A Rare Side Effect That May Be Due to Tenofovir Disoproxil Fumarate: Nail Pitting

Klimik Dergisi
Infectious DiseasesMicrobiology
2019English

Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady State

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Editorial: Tenofovir Disoproxil Fumarate and Prevention of Mother-To-Child Transmission of Hepatitis B Virus

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy